Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01694953 · ClinicalTrials.gov registry record
The Natural History Study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)
A clinical trial of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE), sponsored by Columbia University.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT01694953 is a study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE) that is actively recruiting participants, run by Columbia University. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01694953, a study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE), is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a multi-center natural history study of Mitochondrial NeurogastroIntestinal Encephalopathy (MNGIE). Patients will be followed over time to assess clinical symptoms. The investigators hope to learn more about the disease of MNGIE as well as develop useful measures of disease status for use in future clinical trials. Additional clinical centers will be listed as they become available.
Conditions Studied
Study Locations (1)
New York
- Columbia University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-02 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01694953
The ClinicalTrials.gov registry entry for NCT01694953 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE) appearing as the primary indexed condition, and to 0 interventions.
NCT01694953 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01694953 about?
NCT01694953 is a clinical study titled "The Natural History Study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)". This is a multi-center natural history study of Mitochondrial NeurogastroIntestinal Encephalopathy (MNGIE). Patients will be followed over time to assess clinical symptoms. The investigators hope to learn more about the disease of MNGIE as well as develop useful measures of disease status for use in...
What is the current status of trial NCT01694953?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2013-02. Estimated completion is 2026-12.
What conditions does trial NCT01694953 study?
This clinical trial studies the following conditions: Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE).
Who is sponsoring clinical trial NCT01694953?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01694953 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.